Atrial Fibrillation in the US 3-Fold More Prevalent Than Previously Estimated, New Data Suggest
Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.
How to Define an Atopic Dermatitis Flare: Survey Seeks New Patient Consensus
The term "flare" is used consistently in discussions of AD, but is everyone talking about the same thing? New research closes in on a patient-centered definition.
Best States for Health Care in the US: 2024
Which state retains the most medical residents? Or has the lowest cancer rate? Answers and more insights from a nationwide analysis, here.
GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3
The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.
Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose
Your daily dose of the clinical news you may have missed.
sNDA Goes to FDA for neffy 1 mg for Young Children with Type 1 Allergic Reactions
The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.
Mammography Centers Now Mandated to Disclose Breast Density
Regulations have been amended under the Mammography Quality Standards Act of 1992 to ensure women receive quality mammography for early breast cancer detection and prevention.
Congenital Adrenal Hyperplasia Management Across the Lifespan
The cortisol deficiency central to congenital adrenal hyperplasia requires lifelong treatment with distinct shifts in management required at each developmental stage.
Healthy Lifestyle May Offset Brain Aging Accelerated by Diabetes: Daily Dose
Lebrikizumab Therapy Improved QoL, Mental Health Outcomes in Patients with Atopic Dermatitis
In a study of persons with moderate-to-severe atopic dermatitis, lebrikizumab monotherapy for 16 weeks resulted in improved quality of life and mental health.
RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC Data
The new data amend that from prelicensure trials, which did not include fair representation of older adults and others more vulnerable to severe RSV disease.
FDA Expands Omnipod 5 AID System Label to Treat T2D: Daily Dose
Novel GLP-1 RA for Obesity Shows Promise in Early Phase 1 Trial
Once-daily oral TERNS-601 was associated with a significant mean 5% weight reduction after 28 days and had a favorable tolerability profile.
Tralokinumab May be Beneficial for Atopic Dermatitis Treatment in Special Patient Populations
In a study of patients with atopic dermatitis, tralokinumab was effective and safe in elderly patients and those with severe comorbidities.
CDC COVID-19 Vaccine Bridge Access Program Ends 4 Months Earlier than Planned
The Bridge Access Program allowed Americans who are uninsured or underinsured to receive COVID-19 vaccination at not cost and was ended abruptly last month.
Global Study Builds on Previous Research Linking Semaglutide & Suicide: Daily Dose
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPD
In a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.
CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose
Many Patients with Chronic Hand Eczema Report Having Corticosteroid Phobia, Shows New Research
In a study of patients with CHE, 75.5% of participants totally or almost agreed that topical corticosteroids cause damage to skin.
